Results 11 to 20 of about 121,270 (259)

Neuroendocrine Tumor Markers

open access: yesFrontiers in Neuroendocrinology, 2001
Tumor markers used in the diagnosis and follow-up of patients with neuroendocrine tumors are in most instances not specific for a given tumor and circulate under normal conditions in the serum, making their use as an early diagnostic tool difficult (low sensitivity).
Lamberts, S.W.J.   +2 more
openaire   +2 more sources

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review

open access: yesDiagnostics, 2015
To date, empirical literature has generally been considered lacking in relation to neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine neoplasms.
Emma Elizabeth Ilett   +5 more
doaj   +1 more source

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

open access: yesBMC Cancer, 2020
Background High grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) with a Ki67 proliferation index > 20%, include well-differentiated tumours grade 3 (NET G3) and poorly differentiated (PD) neuroendocrine carcinomas (NEC).
Kirstine Nielsen   +8 more
doaj   +1 more source

Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study

open access: yesBMC Cancer, 2020
Background The worldwide prevalence and incidence of neuroendocrine neoplasms (NEN) have been increasing recently, although few studies have analyzed data on the current situation of NENs in Japan.
Toshihiko Masui   +4 more
doaj   +1 more source

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy

open access: yesFrontiers in Endocrinology, 2023
IntroductionAlthough appendicitis occurs in approximately 1:1000 pregnancies, appendiceal neuroendocrine neoplasm (ANEN) diagnosis during pregnancy is very rare.
Orit Twito   +11 more
doaj   +1 more source

Neuroendocrine tumor theranostics

open access: yesCancer Science, 2022
AbstractTheranostics is a term coined by combining the words “therapeutics” and “diagnostics,” referring to single chemical entities developed to deliver therapy and diagnosis simultaneously. Neuroendocrine tumors are rare cancers that occur in various organs of the body, and they express neuroendocrine factors such as chromogranin A and somatostatin ...
Yasushi Ichikawa   +5 more
openaire   +2 more sources

Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET/CT studies?

open access: yesEJNMMI Physics, 2021
Background Image quality and quantitative accuracy of positron emission tomography (PET) depend on several factors such as uptake time, scanner characteristics and image reconstruction methods. Ordered subset expectation maximization (OSEM) is considered
Alexandre Chicheportiche   +7 more
doaj   +1 more source

Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2016
A 55-year-old woman diagnosed with sporadic MTC underwent total thyroidectomy 20 years ago. After the first surgery, elevated calcitonin levels in parallel with local disease persistence were noted and therefore she underwent repeated neck dissections ...
Hashem Bseiso   +3 more
doaj   +1 more source

Renal neuroendocrine tumors

open access: yesIndian Journal of Urology, 2009
Neuroendocrine tumors (NETs) are uncommon tumors that exhibit a wide range of neuroendocrine differentiation and biological behavior. Primary NETs of the kidney, including carcinoid tumor, small cell carcinoma (SCC), and large cell neuroendocrine carcinoma (LCNEC) are exceedingly rare.The clinicopathologic features of renal NETs diagnosed at a single ...
Brian R Lane, George Jour, Ming Zhou
openaire   +3 more sources

Gastroenteropancreatic Neuroendocrine Tumors [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 2018
Abstract Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their incidence has steadily increased in the last 3 decades.
Cives, Mauro, Strosberg, Jonathan R
openaire   +3 more sources

Home - About - Disclaimer - Privacy